secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0000950170-25-024228
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health extends maturity of $6.22M secured note to Jan 20, 2026
---------------------------------------------------------------------

- Note originally issued Jan 19, 2021; maturity extended from undated to Jan 20, 2026.
- Principal amount remains $6,220,812.50; no other terms changed publicly.
- Amendment dated Feb 13, 2025 between Jaguar Health, Napo Pharma, and Streeterville Capital.
- Extension provides additional time to repay; no default or acceleration mentioned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025024228/0000950170-25-024228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025024228/jagx-20250219.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-024228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer